Brightsurf Science News & Current Events

November 15, 2014
High impact clinical trials yield results that could lead to improved kidney care
The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2014, Nov.

Keryx announces results from ferric citrate phase 3 long-term safety extension study
Keryx Biopharmaceuticals, Inc. today announced results from a 48-week Open Label Extension (OLE) safety study in which Ferric Citrate demonstrated long-term safety and efficacy in dialysis-dependent chronic kidney disease patients with elevated serum phosphorus levels, or hyperphosphatemia.

Access to specialized kidney care varies by geographic area and race
Patients' access to specialized care before kidney failure develops varies significantly across the United States and among different racial groups.

Aspirin or blood pressure medication before and after surgery does not reduce risk of AKI
In patients undergoing noncardiac surgery, neither aspirin nor clonidine (a medication primarily used to treat high blood pressure) taken before and after surgery reduced the risk of acute kidney injury, according to a study appearing in JAMA.

Potassium additives may make low-sodium meats unsafe for patients with kidney disease
Potassium additives are frequently added to sodium-reduced meat products in amounts that may be dangerous for patients with kidney disease.

Osteoporotic fractures cost China's healthcare system close to 10 billion USD annually
An epidemiological study presented at the 5th Asia-Pacific Osteoporosis Meeting is one of the first to project the immense and growing economic cost of osteoporotic fractures in China.

Home dialysis may be better than in-center hemodialysis for patients with kidney failure
Home dialysis therapies may help prolong the lives of patients with kidney failure compared with hemodialysis treatments administered in medical centers.

Resuscitation science tip sheet
American Heart Association pre-arrival telephone CPR guidelines help save lives.

Use of antibiotic following kidney transplantation does not prevent virus infection
Among kidney transplant recipients, a three-month course of the antibiotic levofloxacin following transplantation did not prevent the major complication known as BK virus from appearing in the urine.

Perceived racial discrimination may impact kidney function
Perceived racial discrimination may contribute to disparities related to kidney disease.

Healthy diets are good for the kidneys
A healthy diet may help protect the kidneys.

ASN Kidney Week late-breaking clinical studies highlight advances in kidney care
The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2014, Nov.

Chemotherapy following radiation treatment slows disease progress
A chemotherapy regimen consisting of procarbazine, CCNU, and vincristine administered following radiation therapy improved progression-free survival and overall survival in adults with low-grade gliomas, a form of brain cancer, when compared to radiation therapy alone.

Winners of IOF Young Investigators Awards announced in Taipei
Researchers from Australia, Hong Kong/China, Malaysia, and Singapore received the International Osteoporosis Foundation's Young Investigators Awards, presented at the IOF Regionals - 5th Asia-Pacific Osteoporosis Meeting in Taipei.

Air pollution associated with higher rates of chronic kidney disease
Air pollution may play a role in the development of kidney disease.

Study finds weight loss of 10 percent or more in seniors significantly raises hip fracture risk
The findings of a new study presented today at the IOF Regionals Asia-Pacific Osteoporosis Meeting in Taipei, show that among middle-aged to elderly Singapore Chinese, weight loss of 10 percent or more was associated with a 56 percent higher hip fracture risk.

Two drugs are no more effective than 1 to treat common kidney disease
Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health.

Blood test could prevent medication trial and error for rheumatoid arthritis patients
A molecule in the blood shows promise as a marker to predict whether individual rheumatoid arthritis patients are likely to benefit from biologic medications or other drugs should be tried, a Mayo Clinic-led study shows. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to